InvestorsHub Logo
Followers 15
Posts 1158
Boards Moderated 0
Alias Born 12/21/2010

Re: revenue_monster post# 215999

Saturday, 04/18/2015 2:42:48 PM

Saturday, April 18, 2015 2:42:48 PM

Post# of 345747

Competition is brutal in biotech especially against big boys. Patients might feel compelled to opt for opdivo vs doce/ Bavi due to recent results, as well as moving away from standard chemo treatments



RM did you miss reading the post from Bio and CP that we may do fine for THIS YEAR since Opdivo is approved only in US and not for this indication and lot of other reasons ?

Looks like people have to wait for another 4-6 months at a mininum to opt for Opdivo. If you don't think what Bio and CP put forth is not true can you share your thoughts why it is so bad for our enrollment ?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News